Click Banner For More Info See All Sponsors

So Long and Thanks for All the Fish!

This site is now closed permanently to new posts.
We recommend you use the new Townsy Cafe!

Click anywhere but the link to dismiss overlay!

Results 1 to 2 of 2

  • Share this thread on:
  • Follow: No Email   
  • Thread Tools
  1. TopTop #1
    Mayacaman's Avatar
    Mayacaman
     

    Johns Hopkins, CDC Plan to Mask Medical Experimentation on Minorities as “Racial Justice"




    The Johns Hopkins, CDC Plan to Mask Medical
    Experimentation on Minorities as “Racial Justice”

    By Jeremy Lofredo & Whitney Webb

    Under the guise of combatting “structural racism,” the Johns Hopkins Center for Health Security has laid out a strategy for ethnic minorities and the mentally challenged to be vaccinated first, all “as a matter of justice.” However, other claims made by the Center contradict these social justice talking points and point to other motives entirely.


    With the first COVID-19 vaccine candidate set to receive an Emergency Use Authorization (EUA) from the US government in a matter of days, its distribution and allocation is set to begin “within 24 hours” of that vaccine’s imminent approval.

    The allocation strategy of COVID-19 vaccines within the US is set to dramatically differ from previous national vaccination programs. One key difference is that the vaccine effort itself, known as Operation Warp Speed, is being almost completely managed by the US military, along with the Department of Homeland Security (DHS) and the National Security Agency (NSA), as opposed to civilian health agencies, which are significantly less involved than previous national vaccination efforts and have even been barred from attending some Warp Speed meetings. In addition, for the first time since 2001, law enforcement officers and DHS officials are set to not be prioritized for early vaccination.


    Another key difference is the plan to utilize a phased approach that targets “populations of focus” identified in advance by different government organizations, including the CDC’s Advisory Committee on Immunization Practices (ACIP). Characteristics of those “populations of focus,” also referred to as “critical populations” in official documentation, will then be identified by the secretive, Palantir-developed software tool known as “Tiberius” to guide Operation Warp Speed’s vaccine distribution efforts. Tiberius will provide Palantir access to sensitive health and demographic data of Americans, which the company will use to “help identify high-priority populations at highest risk of infection.”


    This report is the first of a three-part series unmasking the racist components of the Pentagon-run project to both develop and distribute a COVID-19 vaccine. It explores the COVID-19 vaccine allocation strategy first outlined by the Johns Hopkins Center for Health Security and subsequent government allocation strategies that were informed by Johns Hopkins.


    The main focus of this allocation strategy is to deliver vaccines first to racial minorities but in such a way as to make those minorities feel “at ease” and not like “guinea pigs” when receiving an experimental vaccine that those documents admit is likely cause “certain adverse effects…more frequently in certain population subgroups.” Research has shown that those “subgroups” most at risk for adverse effects are these same minorities.


    The documents also acknowledge that information warfare and economic coercion will likely be necessary to combat “vaccine hesitancy” among these minority groups. It even frames this clearly disproportionate focus on racial minorities as related to national concerns over “police brutality,” claiming that giving minorities the experimental vaccine first is necessary to combat “structural racism” and ensure “fairness and justice” in the healthcare system and society at large.


    Part 2 of this series will discuss how Palantir, a company currently helping DHS and law enforcement violently target African Americans and Latinos, will be in charge of allocating “tailored” COVID-19 vaccines to those same minorities as well as Palantir’s origins and its executives’ views on race. Part 3 will explore the direct ties between a COVID-19 vaccine front-runner and the Eugenics Society, which was re-named the Galton Institute in 1989.


    The Planners

    The Trump administration been criticized for its rush to develop and deploy a COVID-19 vaccine and particularly for installing Monclef Slaoui, a former pharmaceutical executive with ongoing conflicts of interest, as chief scientific adviser for Operation Warp Speed, the Pentagon-run program to produce and distribute the vaccine. Yet, if and when a Biden administration takes power, Operation Warp Speed is set to proceed with little, if any, modification.

    The Johns Hopkins Center for Health Security (CHS) director Tom Inglesby, who will serve on the Biden Health and Human Services (HHS) transition team, has praised Slaoui, telling Stat News that the longer someone like him can remain in charge of the nation’s COVID-19 vaccine effort, “the better it is for the country.”


    Inglesby, who led discussions at the CHS’s Event 201 exercise in October 2019 and who was one of the primary authors of the controversial Johns Hopkins Dark Winter exercise in 2001, is emblematic of the US government’s and the mainstream media’s general reliance on the Johns Hopkins Bloomberg School of Public Health (of which CHS is part) for pandemic-related matters. Slaoui regularly appears on network TV as a COVID-19 oracle and has been called “one of the nation’s go-to experts on the spread of the coronavirus.” Readers may note that the Johns Hopkins “coronavirus tracker” has been used by virtually every mainstream news source since the beginning of COVID-19 reporting. This relationship is expected to continue, if not intensify, in a Biden administration.


    Both
    Kathleen Hicks, the lead on Biden’s Department of Defense (DOD) transition team, and Alexander Bick, on Biden’s National Security Council transition team, are scholars at Johns Hopkins Kissinger Center for Global Affairs, reflecting the university’s broader influence on a future Biden administration. Yet, the most significant way the Biden transition intersects with Johns Hopkins is through the CHS.

    Originally called the Center for Civilian Biodefense Strategies, the CHS is a think tank within Johns Hopkins that regularly gives recommendations to both the US government and the World Health Organization and, like the Bill and Melinda Gates Foundation, has emerged as a voice of authority on all matters COVID-19 in the US. The center’s founding director was D. A. Henderson, best known for his role in the WHO-sponsored smallpox vaccination campaign. Henderson also held several government positions, including serving as associate director of the Office of Science and Technology Policy under George H. W. Bush. He was also the longtime dean of the Johns Hopkins School of Public Health.

    Another member of the Biden transition team is Luciana Borio, a current member of the CHS steering committee. As both a former FDA scientist and former National Security Council member, Borio signifies the relationship between the national security state and the biosecurity state. She’s currently a vice president of In-Q-Tel, the venture-capital arm of the CIA.

    In-Q-Tel’s current executive vice president, Tara O’Toole, who at the onset of the COVID-19 outbreak declared that “the best way ever to protect those who are well is with vaccines,” is Inglesby’s mentor and predecessor as director of the CHS. She was also a key player and the lead author of the CHS’s Dark Winter and CladeX bioterror simulations. The Engineering Contagion series published by The Last American Vagabond earlier this year explored the Dark Winter simulation in depth, including how the simulation eerily predicted the 2001 anthrax attacks that followed soon after September 11, 2001, with several participants demonstrating apparent foreknowledge of those attacks.

    Ending racism with vaccines?

    The Centers for Disease Control and Prevention (CDC) has consistently referenced materials developed by the CHS in its recent COVID-19 vaccine allocation literature. These CDC-issued materials form the backbone of the various vaccine allocation strategies issued by many state governments. Chief among these is the COVID-19 Vaccination Program Interim Playbook, published at the end of October. A key aspect of that program is the determination of “critical populations for COVID-19 vaccination, including those groups identified to receive the first available doses of COVID-19 vaccine when supply is expected to be limited.”

    In August, the CHS published its Inglesby cowritten Interim Framework for COVID-19 Vaccine Allocation and Distribution, which is cited by the CDC as a key reference for its nationwide COVID-19 vaccine-allocation strategy. This report will examine this document, in particular, as well as other related documents that reveal that ethnic and racial minorities, specifically those over sixty-five and those who make up part of the “essential” workforce, are set to be the first to receive experimental COVID-19 vaccines.


    The Interim Framework argues there is a need to prioritize ethnic minorities, particularly African Americans and Latino Americans, in order to reflect “fairness and justice.” It states that “a critical difference” between COVID-19 vaccine allocation and the “context envisioned in the 2018 guidance for pandemic influenza vaccine allocation” is the fact that the US is “currently in the midst of a national reckoning on racial injustice, prompted by cases of police brutality and murder.” It goes on to state that “although structural racism was as present in the 2018 and previous influenza epidemics as it is today, the general public acknowledgment of racial injustice was not.”


    It goes without saying that police brutality is decidedly unrelated to vaccine allocation as is increased national awareness of racial injustice as it relates to police brutality. This is further compounded by the police, in this document, being removed as a priority group for COVID-19 vaccine allocation, despite having been designated a priority group in all other government vaccine-allocation guidance since the 2001 anthrax attacks. Also odd is that it is only increased access of minorities to the COVID-19 vaccine that is cited as a way to address “structural racism in health systems,” not other policies that would be more likely to address the problem such as Medicare for All.

    In addition, the Interim Framework admits that “communities of color, particularly Black populations, may be more wary of officials responsible for vaccine-related decisions due to past medical injustices committed by authorities on Black communities.” There is a long list of these “medical injustices” committed against minority communities by the US government, including the infamous Tuskegee syphilis experiments, which are discussed in detail later.

    Another odd passage on “justice” and “equity” as it relates to vaccinating ethnic minorities first states:

    “In the context of vaccine allocation, treating individuals fairly has sometimes been defined as treating everyone the same or equally, for example, by distributing vaccines on a first-come, first-served basis or by giving everyone an equal chance at getting vaccine via a lottery. Because the impact of the vaccine is different for different people (i.e., some people are at greater risk of death), the straightforward ways of treating people equally are often rejected as unfair or as an inefficient use of vaccine. . . .


    In the context of vaccine allocation, promoting equity and social justice requires addressing higher rates of COVID-19–related severe illness and mortality among systematically disadvantaged or marginalized groups. . . .


    As a matter of justice, these disparities in COVID-19 risk and adverse outcomes across racial and ethnic groups should be addressed in our overall COVID-19 response.”


    This extreme emphasis on the “fairness and justice” of prioritizing minorities for the vaccine is contradicted by other claims made in the same document. For example, the document also states:

    The ultimate safety of an approved vaccine is not completely knowable until it has been administered to millions of people. During clinical trials, tens of thousands of individuals will receive the vaccine but that may fail to show safety concerns that occur with less frequency, such as 1 in a million. This can be a concern for particularly severe adverse effects.”

    It also notes: “It is also possible that certain adverse effects may occur more frequently in certain population subgroups, which may not be apparent until millions are vaccinated.”


    [ Continues...]

    | Login or Register (free) to reply publicly or privately   Email

  2. Gratitude expressed by 2 members:

  3. TopTop #2
    Mayacaman's Avatar
    Mayacaman
     

    Re: Johns Hopkins, CDC Plan to Mask Medical Experimentation on Minorities as “Racial Justi


    Whitney Webb, who co-authored the Article
    ^ (Above) ^
    in a timely interview by Ryan Cristian on


    The Last American Vagabond
    :

    The Eugenicist Mindset Propelling
    Operation Warp Speed w/ Whitney Webb


    | Login or Register (free) to reply publicly or privately   Email

Similar Threads

  1. Righteous Justice Needed for Medical marijuana Mom
    By chronicshawni in forum WaccoTalk
    Replies: 4
    Last Post: 02-08-2011, 04:28 PM
  2. Replies: 6
    Last Post: 08-27-2010, 08:32 PM
  3. Same-Sex Marriage and Racial Justice Find Common Ground
    By Zeno Swijtink in forum WaccoReader
    Replies: 1
    Last Post: 05-17-2008, 06:20 AM

Tags (user supplied keywords) for this Thread

Bookmarks